MyoKardia Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (28)

View All

Latest Posts

About This Stock More About This Stock
MYOK Swings Higher On Buyout Buzz
Article By: Schaeffers Research
Monday, October 5, 2020 12:10 PM EDT
Bristol-Meyers will buy MyoKardia for roughly $13 billion.
In this article: BMY, MYOK
Read
4 Small Cap Biotechs With Upcoming Catalysts
Article By: Scott Matusow
Wednesday, January 10, 2018 7:20 PM EDT
The biotech “run-up” trade has always attracted a wide array of traders looking to take advantage of potentially high alpha price moves before the actual catalyst/binary event come to fruition.
In this article: JNCE, MYOK, GTHX, SRRA Also: MRK, RHHBY, VRTX, LLY, XBI
Read
Best Sector ETF Of Q3 And Its Top-Performing Stocks
Article By: Sweta Killa
Monday, October 2, 2017 3:08 PM EDT
The biotech sector led the U.S. stock market higher last quarter with Virtus LifeSci Biotech Clinical Trials ETF topping the list of the best-performing ETFs, logging impressive returns of about 21.4%.
In this article: SGMO, DVAX, INSM, KITE, MYOK, BBC
Read
3 Soaring Hot Stocks With Big Insider Buying
Article By: TipRanks
Thursday, August 24, 2017 1:30 PM EDT
Let’s check out the three soaring stocks that are seeing particularly interesting insider buying right now.
In this article: MYOK, BGNE, IPI Also: CELG
Read
MyoKardia Brings Hope To Hypertrophic Cardiomyopathy Patients
Article By: Scott Matusow
Tuesday, July 11, 2017 10:44 AM EDT
Obstructive Hypertrophic Cardiomyopathy affects roughly 1 out of 500 persons in the U.S, and globally. MyoKardia based on my research has a good chance to successfully treat this highly underserved and unmet need patient population.
In this article: MYOK Also: SNY, GLYC, CALA
Read
All Posts

Latest Tweets for $MYOK

No tweets yet!

PARTNER HEADLINES